MP74-02 FREE SERUM TESTOSTERONE VERSUS TOTAL TESTOSTERONE AS SURROGATE MARKER FOR THE CLINICAL BENEFIT OF ANDROGEN SUPPRESSION IN PROSTATE CANCER PATIENTS
Regis, Lucas, Iztueta, Ignacio, Servian, Pol, Kosntantinidis, Cristian, Planas, Jacques, Celma, Ana, Placer, Jose, DeTorres, Ines, Morote, JuanVolume:
191
Language:
english
Journal:
The Journal of Urology
DOI:
10.1016/j.juro.2014.02.2335
Date:
April, 2014
File:
PDF, 238 KB
english, 2014